21 years ago Zithromax gained FDA approval. Zithromax is a drug manufactured by Pfizer to treat common infections including respiratory infections such as bronchitis, pneumonia, and sinusitis. The five day course of treatment has made Zithromax a popular antibiotic among patients. However, as the drug marks its 21st birthday this year, a new study has come out that has some experts concerned about its safety.
The study published in a recent issue of the New England Journal of Medicine found that Zithromax users face twice the risk of sudden cardiac death as users of other types of antibiotics. Those at greatest risk of Zithromax sudden cardiac death appear to be those with pre-existing heart conditions.
While the FDA is recommending that people taking Zithromax continue to do so, it is important to know that the potential risk / benefit calculation has changed and that safer options may exist. Before you agree to treatment for your next infection, please talk to your doctor about your risks and about the potential benefits of your antibiotic options.